Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Capital Leases (2017 - 2019)

Historic Capital Leases for Phibro Animal Health (PAHC) over the last 3 years, with Q2 2019 value amounting to $40000.0.

  • Phibro Animal Health's Capital Leases fell 6610.17% to $40000.0 in Q2 2019 from the same period last year, while for Jun 2019 it was $40000.0, marking a year-over-year decrease of 6610.17%. This contributed to the annual value of $40000.0 for FY2019, which is 6610.17% down from last year.
  • As of Q2 2019, Phibro Animal Health's Capital Leases stood at $40000.0, which was down 6610.17% from $60000.0 recorded in Q1 2019.
  • Phibro Animal Health's Capital Leases' 5-year high stood at $182000.0 during Q3 2017, with a 5-year trough of $40000.0 in Q2 2019.
  • In the last 3 years, Phibro Animal Health's Capital Leases had a median value of $108500.0 in 2018 and averaged $110625.0.
  • In the last 5 years, Phibro Animal Health's Capital Leases plummeted by 4560.44% in 2018 and then plummeted by 6610.17% in 2019.
  • Over the past 3 years, Phibro Animal Health's Capital Leases (Quarter) stood at $166000.0 in 2017, then plummeted by 53.61% to $77000.0 in 2018, then tumbled by 48.05% to $40000.0 in 2019.
  • Its Capital Leases stands at $40000.0 for Q2 2019, versus $60000.0 for Q1 2019 and $77000.0 for Q4 2018.